Clinical Trial Update: Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for a gene transfer approach targeting recessive dystrophic epidermolysis bullosa has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa
• Epidermolysis Bullosa Dystrophica

Drugs mentioned

• Gene transfer therapy for recessive dystrophic epidermolysis bullosa

Snippet

Sponsor: Abeona Therapeutics, Inc | Conditions: Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-07-10